Metis Global Partners LLC Acquires 1,013 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Metis Global Partners LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,140 shares of the medical equipment provider’s stock after purchasing an additional 1,013 shares during the period. Metis Global Partners LLC’s holdings in Intuitive Surgical were worth $8,946,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical in the fourth quarter valued at about $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical in the fourth quarter valued at about $82,517,000. Sycomore Asset Management boosted its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $573.15 on Friday. The business’s 50 day simple moving average is $569.87 and its 200 day simple moving average is $528.64. The firm has a market cap of $204.14 billion, a PE ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 2,401 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $205,093. This represents a 87.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,077 shares of company stock worth $4,620,025 over the last ninety days. 0.80% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Jefferies Financial Group increased their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.